James A. Mastrianni to Alzheimer Disease
This is a "connection" page, showing publications James A. Mastrianni has written about Alzheimer Disease.
Connection Strength
1.155
-
"Dual Disease" TgAD/GSS mice exhibit enhanced Alzheimer's disease pathology and reveal PrPC-dependent secretion of Aß. Sci Rep. 2019 06 12; 9(1):8524.
Score: 0.524
-
In vivo parahippocampal white matter pathology as a biomarker of disease progression to Alzheimer's disease. J Comp Neurol. 2013 Dec 15; 521(18):4300-17.
Score: 0.358
-
Systemic transthyretin amyloidosis in a patient with bent spine syndrome. Amyloid. 2013 Jun; 20(2):131-4.
Score: 0.086
-
Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype. Ann Neurol. 2011 Apr; 69(4):712-20.
Score: 0.074
-
Prion protein codon 129 genotype prevalence is altered in primary progressive aphasia. Ann Neurol. 2005 Dec; 58(6):858-64.
Score: 0.051
-
A familial case of Alzheimer's disease without tau pathology may be linked with chromosome 3 markers. Hum Genet. 1999 Jul-Aug; 105(1-2):32-7.
Score: 0.033
-
Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study. Neurology. 1997 Dec; 49(6):1513-21.
Score: 0.029